COMMUNIQUÉS West-GlobeNewswire

Oasmia Pharmaceutical Strengthens its Management Team and Organization

06/03/2019 - 08:30

To increase resources and its business development function, Oasmia has employed Anette Sjödin as Executive Vice President to focus on commercialization and business development. The organization is further strengthened [...]

LIDDS: Final patient enrolled in Phase IIb Liproca® Depot prostate cancer study

06/03/2019 - 08:19

The last patient has been enrolled in LIDDS Phase IIb study for the localized treatment of prostate cancer. The Phase IIb study will identify the optimal dose for Phase III and test the safety of Liproca ® Depot and its [...]

Recording of the Fourth Quarter 2018 Investor Conference Webinar

06/03/2019 - 08:07

On March 5 JSC Olainfarm organized its Investor Conference - Online Webinar. During the webinar the Advisor to the Board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of fourth quarter and 12 months of [...]

Nicox : Résultats financiers 2018 et étapes clés en 2019

06/03/2019 - 07:31

Communiqué de presse Nicox : Résultats financiers 2018 et étapes clés en 2019 ................................................. Augmentation de 74% du chiffre d'affaires net 1 Réduction de la perte avant impôt en 2018 [...]

Nicox Announces 2018 Financial Results and 2019 Milestones

06/03/2019 - 07:31

Press Release Nicox Announces 2018 Financial Results and 2019 Milestones ................................................ Net revenue 1 increased by 74% Loss before tax in 2018 reduced compared to 2017 Cash balance and [...]

ERYTECH to Host Fourth Quarter and Full Year 2018 Conference Call and Business Update

06/03/2019 - 07:30

LYON, France, March 06, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]

ERYTECH tiendra un webcast le 12 mars 2019 à l’occasion de ses résultats annuels 2018

06/03/2019 - 07:30

LYON, France, 06 mars 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les [...]

Akcea et Ionis obtiennent un avis positif du CHMP de l'UE concernant WAYLIVRA™ (volanesorsen)

06/03/2019 - 06:30

Premier et unique traitement approuvé pour le FCS, une maladie grave et rare pour laquelle aucun traitement n’est approuvé BOSTON, Massachusetts et CARLSBAD, Californie, 06 mars 2019 (GLOBE NEWSWIRE) -- Akcea [...]

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

06/03/2019 - 02:07

COPENHAGEN, Denmark, March 05, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon TM technology to address unmet medical needs, today announced [...]

Sarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock

06/03/2019 - 01:32

CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public [...]

REVA Announces Extension to Voluntary Suspension of Trading

06/03/2019 - 01:29

SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 6 March 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]

MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan

06/03/2019 - 00:51

LA JOLLA, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

WW – the new Weight Watchers – Announces Participation in Upcoming Investor Conferences

06/03/2019 - 00:32

NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WTW) (“WW”), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy [...]

Intercept to Present at Upcoming Investor Conferences

05/03/2019 - 23:00

NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Dova Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

05/03/2019 - 22:45

DURHAM, N.C., March 05, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the Cowen [...]

Molecular Templates to Present a Corporate Overview at the Cowen & Company 39th Annual and the Oppenheimer & Co. 29th Annual Health Care Conferences

05/03/2019 - 22:30

AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

Dragon Jade Announces Appointments of New Independent Directors and Formation of Nominating and Compensation Committees

05/03/2019 - 22:30

HONG KONG, March 05, 2019 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced the appointments of Mr. David [...]

Retrophin to Present at Upcoming Investor Conferences

05/03/2019 - 22:30

SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the following upcoming investor conferences in March: Cowen [...]

The Cooper Companies Announces First Quarter 2019 Results

05/03/2019 - 22:15

PLEASANTON, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal first quarter ended January 31, 2019. Revenue increased 6% year-over-year to [...]